Tilray is one of the largest and most sophisticated producers of premium medical cannabis in the world. We are dedicated to providing safe, consistent and reliable therapy to patients. As regulations evolve, we are well-positioned to bring our expertise to help launch mature and professional medical cannabis markets.


b-07.png

EXPERIENCE

Tilray is the only American-owned company to be a federally licensed producer of medical cannabis. In less than a year we built a $26 million, 60,000 sq. ft. state-of the art research and production facility and assembled an industry-leading team of more than 120 experts.

PRECISION

Tilray's cultivation and processing practices are the most advanced in the industry. We are currently cultivating 40,000+ plants representing 50+ strains. Our products are tested for potency and purity before being safely packaged and clearly labeled for patients.

Lima01.jpg

RESEARCH

We are committed to scientific research that leads to an improved quality of life for patients in a time frame that matters. We are partnering with leading physicians, hospitals and universities to advance the scientific understanding of the therapeutic value and clinical applications of cannabinoids.

x-06.png

CARE

Tilray proudly supplies thousands of patients with a range of medical cannabis products. We take pride in our customer service, patient outreach, and physician interaction. We recognize the importance of tracking potential adverse events as well as therapeutic benefits in order to ensure the safety of our patients.


ADVANCING CANNABINOID SCIENCE

For the therapeutic value and risks of cannabinoid-based medicines to be fully understood, Tilray believes it is critical to evolve current scientific understanding of the field. Our clinical research program is designed with that in mind. We understand the importance of developing well-characterized, consistent preparations of specific cannabinoid compositions that meet regulatory agencies’ standards for use in clinical research.


PRODUCTS & STRAIN VARIETIES

Tilray cultivates a wide range of strains to meet patient needs including indicas, sativas, hybrids, and CBD-rich varieties. Medical cannabis is available in two primary forms: dried flower and extracts. Each can be administered or consumed via a variety of methods. Tilray is working closely with patients, physicians, and regulators to provide consistent availability of a range of compliant and effective forms of medical cannabis.


FACILITY TOUR

Our aspiration is to build the world’s most trusted and admired medical cannabis brand. As laws and regulations governing medical cannabis evolve in different jurisdictions, we are actively seeking to expand our operations.


CANADA Tilray is a leading provider of medical cannabis in Canada, supplying thousands of patients in every province with consistent access to high quality medical cannabis. LeArn More →

CANADA

Tilray is a leading provider of medical cannabis in Canada, supplying thousands of patients in every province with consistent access to high quality medical cannabis.

LeArn More →

CROATIA Tilray is expanding its efforts into the EU as the first company to legally export medical cannabis products from North America to the European Union, supplying precisely crafted medical cannabis products to Croatia to be dispensed to patients with prescriptions via pharmacies. LEARN MORE →

CROATIA

Tilray is expanding its efforts into the EU as the first company to legally export medical cannabis products from North America to the European Union, supplying precisely crafted medical cannabis products to Croatia to be dispensed to patients with prescriptions via pharmacies.

LEARN MORE →

U.S. Tilray is expanding to the U.S. through investments in prospective applicants and license holders.   Learn More →

U.S.

Tilray is expanding to the U.S. through investments in prospective applicants and license holders.
 

Learn More →

AUSTRALIA Tilray is expanding its research efforts to Australia in partnership with leading hospitals and universities, and also supplying patients via compassionate access regulations.   LEARN MORE →

AUSTRALIA

Tilray is expanding its research efforts to Australia in partnership with leading hospitals and universities, and also supplying patients via compassionate access regulations.

 

LEARN MORE →

EUROPE Tilray is expanding its operations and research efforts to Europe, where medical cannabis laws and attitudes are rapidly evolving. Learn More →

EUROPE

Tilray is expanding its operations and research efforts to Europe, where medical cannabis laws and attitudes are rapidly evolving.

Learn More →


Tilray's diverse team of industry-leading experts includes PhD research scientists, master horticulturists, engineers, former pharmaceutical executives, patient advocates and former law enforcement officers. Click on team members to see their bios.


THE TILRAY WAY